Soriano-Moreno David R, Soriano-Moreno Anderson N, Mejia-Bustamante Angela, Guerrero-Ramirez Cristhian A, Toro-Huamanchumo Carlos J
School of Medicine, Universidad Peruana Unión, Lima, Peru.
School of Medicine, Universidad Particular de Chiclayo, Chiclayo, Peru.
Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:114-120. doi: 10.1016/j.ejogrb.2019.12.017. Epub 2019 Dec 24.
This study aimed to assess the factors associated with highly effective contraceptive (HEC) use among reproductive-age women in Peru, using evidence from a nationwide survey.
We analyzed the data corresponding to a national representative sample of 30,169 Peruvian women aged 15-49 years, surveyed during the Demographic and Family Health Survey, 2017. Usage of HEC methods included pills, IUD, injections, sterilization and implant. We assessed the factors associated with its use using Poisson regression models, reporting the crude (cPR) and adjusted prevalence ratios (aPR) with their respective 95 % confidence intervals (95 % CI).
The prevalence of HEC use was 29.9 %. Factors related to a more likely use of HEC methods were having one (aPR: 4.03; 95 % CI: 3.19-5.09) or more children (aPR: 5.60; 95 % CI: 4.42-7.09), and having a health insurance children (aPR: 1.14; 95 % CI: 1.05-1.24). Women from the highlands (aPR: 0.74; 95 % CI: 0.67-0.81), aged ≥35 years (aPR: 0.78; 95 % CI: 0.67-0.90), not currently married or cohabiting (aPR: 0.52; 95 % CI: 0.47-0.58), and who considered it really hard to have to take transportation when they need medical help or advice (aPR: 0.92; 95 % CI: 0.86-0.99) were less likely to use highly effective contraception.
Quality and access to reproductive health is still a challenge in Peru. Family planning programs should be better disseminated and integrated. Similarly, promotion of educational campaigns and easy access to HEC methods are needed.
本研究旨在利用一项全国性调查的证据,评估秘鲁育龄妇女中与高效避孕方法(HEC)使用相关的因素。
我们分析了2017年人口与家庭健康调查期间对30169名年龄在15至49岁的秘鲁女性进行全国代表性抽样调查的数据。高效避孕方法的使用包括口服避孕药、宫内节育器、注射、绝育和植入。我们使用泊松回归模型评估与其使用相关的因素,报告粗患病率比(cPR)和调整患病率比(aPR)及其各自的95%置信区间(95%CI)。
高效避孕方法的使用率为29.9%。与更可能使用高效避孕方法相关的因素是育有一个(aPR:4.03;95%CI:3.19 - 5.09)或更多子女(aPR:5.60;95%CI:4.42 - 7.09),以及子女有健康保险(aPR:1.14;95%CI:1.05 - 1.24)。来自高地的女性(aPR:0.74;95%CI:0.67 - 0.81)、年龄≥35岁的女性(aPR:0.78;95%CI:0.67 - 0.90)、目前未婚或未同居的女性(aPR:0.52;95%CI:0.47 - 0.58),以及认为在需要医疗帮助或建议时很难乘坐交通工具的女性(aPR:0.92;95%CI:0.86 - 0.99)使用高效避孕方法的可能性较小。
在秘鲁,生殖健康的质量和可及性仍然是一项挑战。计划生育项目应得到更好的推广和整合。同样,需要开展教育宣传活动并使高效避孕方法易于获取。